BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31335442)

  • 21. Biofilm related infections: is there a place for conservative treatment of port-related bloodstream infections?
    del Pozo JL; Serrera A; Martinez-Cuesta A; Leiva J; Penades J; Lasa I
    Int J Artif Organs; 2006 Apr; 29(4):379-86. PubMed ID: 16705606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biofilms: survival mechanisms of clinically relevant microorganisms.
    Donlan RM; Costerton JW
    Clin Microbiol Rev; 2002 Apr; 15(2):167-93. PubMed ID: 11932229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination d-Amino Acid and Photothermal Hydrogel for the Treatment of Prosthetic Joint Infections.
    Milbrandt NB; Tsai YH; Cui K; Ngompe Massado CS; Jung H; Visperas A; Klika A; Piuzzi N; Higuera-Rueda CA; Samia ACS
    ACS Appl Bio Mater; 2023 Mar; 6(3):1231-1241. PubMed ID: 36867723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biofilms and their role in otorhinolaryngological disease.
    Macassey E; Dawes P
    J Laryngol Otol; 2008 Dec; 122(12):1273-8. PubMed ID: 18405407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of MicroDTTect device and flocked swabs in the diagnosis of prosthetic and orthopaedic infections.
    Calori GM; Colombo M; Navone P; Nobile M; Auxilia F; Toscano M; Drago L
    Injury; 2016 Oct; 47 Suppl 4():S17-S21. PubMed ID: 27492065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial colonization of prosthetic devices and measures to prevent infection.
    Reid G
    New Horiz; 1998 May; 6(2 Suppl):S58-63. PubMed ID: 9654313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of neurosurgical implant-associated infections.
    Conen A; Raabe A; Schaller K; Fux CA; Vajkoczy P; Trampuz A
    Swiss Med Wkly; 2020 Apr; 150():w20208. PubMed ID: 32329803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
    Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
    APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and microbiological aspects of biofilm-associated surgical site infections.
    Edmiston CE; McBain AJ; Roberts C; Leaper D
    Adv Exp Med Biol; 2015; 830():47-67. PubMed ID: 25366220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of bacterial biofilms in chronic infections.
    Bjarnsholt T
    APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiological Diagnosis of Implant-Related Infections: Scientific Evidence and Cost/Benefit Analysis of Routine Antibiofilm Processing.
    Drago L; De Vecchi E
    Adv Exp Med Biol; 2017; 971():51-67. PubMed ID: 27815925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biofilms on central venous catheters: is eradication possible?
    Donlan RM
    Curr Top Microbiol Immunol; 2008; 322():133-61. PubMed ID: 18453275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V; Chifiriuc MC
    Roum Arch Microbiol Immunol; 2010; 69(3):125-38. PubMed ID: 21434589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Koch's postulates to biofilm theory. The lesson of Bill Costerton.
    Ehrlich GD; Arciola CR
    Int J Artif Organs; 2012 Oct; 35(10):695-9. PubMed ID: 23138704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
    Tolker-Nielsen T
    APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections.
    Bowler PG
    J Wound Care; 2018 May; 27(5):273-277. PubMed ID: 29738295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.